Quaker Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
Quaker Wealth Management's SRPT Position: Q3 2026 in Review
Quaker Wealth Management held its Sarepta Therapeutics (SRPT) position steady in Q3 2026 at 400 shares worth $7.29K. The position accounts for ﹤0.01% of the portfolio, ranked #315.
Quaker Wealth Management first reported a position in SRPT in Q2 2025 and has held it in 6 quarters since. The position peaked at $8.7K in Q1 2026. 305 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.
- Quaker Wealth Management held 400 shares of Sarepta Therapeutics worth $7.29K as of Q3 2026.
- Quaker Wealth Management left its Sarepta Therapeutics share count unchanged in Q3 2026.
- Sarepta Therapeutics made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #315 holding.
- Quaker Wealth Management first reported a position in Sarepta Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Quaker Wealth Management's Sarepta Therapeutics position peaked at $8.7K in Q1 2026.
- 305 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.
Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.